Drug Eluting Stents
World’s 1st company to have 2 Drug Eluting Stent technologies with 10 years clinical safety and efficacy data
Our core capabilities encompass every facet of cardiovascular device innovation, from expert manufacturing and cutting-edge clinical research to pioneering R&D, stringent quality control, and thorough regulatory compliance. We are committed to delivering superior heart health solutions through an integrated approach that ensures excellence at every step.
Heal with Polymer Free Technology
Everolimus Eluting Polymer Free stent, offering a unique combination of Probucol and Everolimus. Transever registry supports the safety and efficacy of the ISAR SUMMIT in 1000 patients.
Future Beyond Polymers with 10 Years of Safety and Efficacy Data (ISAR TEST-5)
Longest-studied Polymer-Free Sirolimus-Eluting Stent, with 10 years of proven safety and efficacy data from the ISAR TEST-5 trial. Built on a Cobalt Chromium platform, features a proprietary formulation of Sirolimus with drug delivery matrix of Probucol and Shellac Resin. Probucol replaces traditional polymers, ensuring controlled drug release, enhanced vascular healing, and unmatched safety. The unique micro-porous PEARL surface and abluminal coating further optimize drug delivery and healing.
New generation DES providing synergy
CE-approved Sirolimus-eluting coronary stent with a stainless-steel platform and biodegradable polymer. It features thermally insulated packaging with a TagAlert Device to maintain optimal temperature and prevent Sirolimus degradation.
New generation DES providing synergy
CE-approved Sirolimus-eluting coronary stent built on a microporous stainless-steel platform with a biodegradable polymer. It boasts 10 years of RCT data from the ISAR TEST-4, demonstrating its safety and efficacy compared to the Xience stent. Additionally, it is recommended by the ESC 2018 guidelines.
Redefining Flexibility in Coronary Stents
Sirolimus-eluting biodegradable polymer stent on a Cobalt Chromium platform, designed for enhanced flexibility and navigation through tortuous anatomy. The unique micro-porous PEARL surface and abluminal drug coating optimize drug delivery for longer duration. Backed by 10 years of RCT data, it demonstrates proven safety and efficacy compared to Xience.
Ultimate Trackability for Treating Complexity
CE-approved Sirolimus-Eluting Biodegradable Polymer Coronary Stent features a Cobalt Chromium platform, and a Stent Delivery System designed for balanced performance, making it suitable for use across all types of vessel anatomies. Backed by 10 years of clinical data, it demonstrates proven safety and efficacy.
The Sirolimus-Eluting biodegradable polymer Stent system is built on a Cobalt Chromium platform. Its stent delivery system is optimized for enhanced push ability and deliverability, ensuring smooth navigation and precise placement.
